AI-generated summary
The authors compared side effects of trimipramine alone with trimipramine plus adjunct bright-light therapy in 28 patients with major depression. Response rates were similar between groups and newly emerging side effects were generally low. Compared with drug monotherapy, the combined treatment was associated with more sedation, restlessness, sleep disturbance, decreased appetite and worsened vertigo.
- Participants
- 28
- Who or what was studied
- Patients with non-seasonal major depression (DSM-III-R) randomly assigned to trimipramine or trimipramine plus adjunct bright-light therapy
- Limits stated in the abstract
- The abstract reports a small sample of 28 patients, and it does not state the light wavelength or intensity used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.